LIPPO CHINA RESOURCES LIMITED 力寶華潤有限公司 (Incorporated in Hong Kong with limited liability) （於香港註冊成立之有限公司） （Stock code 股份代號：156） 30 September 2025 Dear Non-registered Shareholders(Note 1), Notification of publication of 2025 Interim Report (the "Interim Report") The Interim Report of Lippo China Resources Limited (the "Company"), in both English and Chinese versions, are now available on the website of the Company at www.lcr.com.hk and the website of The Stock Exchange of Hong Kong Limited (the "Stock Exchang ...

力寶華潤有限公司 變更申請表格 致： 力寶華潤有限公司（「本公司」） 卓佳證券登記有限公司轉交 香港夏慤道16號 遠東金融中心17樓 有關日後公司通訊之選擇：（請僅在一個空格內填上「✓」號） 本人╱吾等擬按下文所示更改本人╱吾等選擇日後公司通訊之收取方式及╱或語言版本： 透過於本公司網站 www.lcr.com.hk 以電子方式閱覽所有公司通訊（可供採取行動之公司通訊除外），以取代收取印刷本，並於郵寄有關公司通訊（可供 採取行動之公司通訊除外）印刷本當日向本人╱吾等發出電郵通知（本人╱吾等之電郵地址如下）或郵寄通知信函至本人╱吾等之地址；或 本人╱吾等之電郵地址： （請確保資料正確填寫以供通知發佈公司通訊之用。） 僅收取英文版印刷本；或 僅收取中文版印刷本；或 同時收取英文及中文版印刷本。 簽署： 日期： 姓名： 聯絡電話： (請以正楷填寫) 附註： 1. 請清楚地填寫此變更申請表格。倘若並無填寫選擇、或沒有簽署、或所填寫之資料不正確，本變更申請表格將會作廢。 2. 如屬聯名股東，則本變更申請表格需由在本公司股東名冊內就聯名持有之股份排名首位之股東簽署，方為有效。 3. 上述指示將適用於日後本公司刊發之所有公 ...

Financial Performance - Revenue for the six months ended June 30, 2025, was HKD 412,108,000, representing a 10.2% increase from HKD 374,147,000 in 2024[4] - Total profit for the period was HKD 256,676,000, up from HKD 231,496,000, indicating an increase of 10.9%[4] - The net loss for the period was HKD 84,202,000, an improvement from a net loss of HKD 150,922,000 in the previous year, reflecting a 44.3% reduction in losses[4] - Other comprehensive income for the period totaled HKD 114,484,000, compared to a loss of HKD 36,678,000 in 2024, showing a significant turnaround[5] - The company reported a basic and diluted loss per share of HKD 0.09, an improvement from HKD 0.15 in the previous year[4] - The company reported a net loss of HKD 10,055,000 for the six months ended June 30, 2025, compared to a net loss of HKD 7,441,000 in the same period of 2024[25] - Basic loss per share remained unchanged at approximately HKD 0.11 for both 2025 and 2024[29] - The company incurred a pre-tax loss of HKD 81,009,000 for the period, highlighting challenges in profitability despite revenue generation[17] Assets and Liabilities - The company's total assets less current liabilities amounted to HKD 2,914,886,000 as of June 30, 2025, down from HKD 2,974,482,000 at the end of 2024[6] - Non-current assets were valued at HKD 2,991,479,000, slightly increasing from HKD 2,945,425,000 in the previous year[6] - The company's cash and cash equivalents decreased to HKD 137,475,000 from HKD 283,187,000, indicating a decline of 51.5%[6] - As of June 30, 2025, the company's total equity amounted to HKD 2,103,084 thousand, an increase from HKD 2,072,928 thousand at the beginning of the year[8] - As of June 30, 2025, total liabilities stood at HKD 1,343,277,000, with property investment liabilities at HKD 209,275,000[19] - The company's current liabilities exceeded its current assets by HKD 76,593 thousand, indicating potential liquidity concerns[12] - The total assets of the group as of June 30, 2025, are HKD 3,400,000,000, down from HKD 3,500,000,000 at the end of 2024[65] - The group's total liabilities decreased to HKD 1,300,000,000 from HKD 1,400,000,000 at the end of 2024[65] Cash Flow - For the six months ended June 30, 2025, the company reported a net cash outflow from operating activities of HKD (11,757) thousand, compared to a net inflow of HKD 17,014 thousand for the same period in 2024[9] - The company reported a financing cash outflow of HKD 125,497 thousand for the six months ended June 30, 2025, significantly higher than HKD 12,236 thousand in the same period of 2024[9] - Cash and cash equivalents decreased by HKD 152,050 thousand during the six months ended June 30, 2025, compared to a decrease of HKD 7,115 thousand in the same period of 2024[9] Segment Performance - For the six months ending June 30, 2025, total revenue reached HKD 412,108,000, with significant contributions from the food business segment at HKD 392,320,000, representing approximately 95.2% of total revenue[17] - The healthcare services segment reported a loss of HKD 2,478,000, while the property management segment generated a profit of HKD 4,942,000, indicating mixed performance across segments[17] - Food manufacturing business revenue reached HKD 202,855,000, up 21.8% from HKD 166,400,000 in the previous year[23] - Restaurant operations revenue increased to HKD 187,787,000, compared to HKD 179,479,000, reflecting a growth of 4.5%[23] - The food business remains the primary revenue source, accounting for 95% of total revenue with a growth rate of 13%[48] Investments and Fair Value - The fair value of financial assets as of June 30, 2025, was HKD 552,970,000, slightly up from HKD 546,264,000 at the end of 2024[38] - The fair value of GSH Corporation Limited's shares held by the company was HKD 76 million, representing 15.4% of the total financial assets at fair value, with an unrealized gain of HKD 13 million during the period[55] - The investment in Amasia CIV, focused on Dialpad, had a fair value of HKD 56 million, accounting for 11.4% of the total financial assets at fair value[56] - The fair value of financial assets classified as other comprehensive income was HKD 50 million, an increase from HKD 46 million at the end of 2024[58] Employee and Operational Costs - Employee costs for the period were HKD 164,177,000, an increase from HKD 154,950,000 in the previous year, reflecting a rise of 6.9%[26] - Other operating expenses decreased to HKD 75 million from HKD 95 million in 2024, primarily due to a reduction in legal and professional fees[48] Shareholder Information - As of June 30, 2025, Dr. Li holds 689,018,438 shares in the company, representing approximately 74.99% of the issued shares[72] - Lippo Capital directly owns 369,800,219 shares in the company, accounting for about 74.98% of its issued shares[73] - The company has a significant stake in Healthway Medical Corporation Limited, holding 3,056,521,494 shares, which is approximately 67.39% of the issued shares[74] - The company’s major shareholders, including Skyscraper Realty Limited and Lippo Capital, collectively hold 689,018,438 ordinary shares, representing approximately 74.99% of the issued shares[79] Corporate Governance - The company has established an audit committee consisting of two independent non-executive directors and one non-executive director, ensuring compliance with accounting principles and financial reporting standards[82] - The board of directors is committed to high-quality corporate governance practices, regularly reviewing governance standards to meet public and shareholder expectations[83] - The company has adopted the standard code for securities trading by directors, confirming compliance during the review period[84]

LIPPO CHINA RESOURCES LIMITED 力寶華潤有限公司 （於香港註冊成立之有限公司） （股份代號：156） 公佈 內幕消息 (1)力寶有限公司實物分派本公司普通股之生效日期；及 (2)本公司股權架構之變動 緒言 香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈之內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示，概不對因本公佈全部或任何部份內容而產生或因倚 賴該等內容而引致之任何損失承擔任何責任。 本公佈乃力寶華潤有限公司（「本公司」，連同其附屬公司，統稱「本集團」）董事會 （「董事會」）根據香港聯合交易所有限公司證券上市規則（「上市規則」）第 13.09(2)(a) 條及香港法例第 571章證券及期貨條例第 XIVA部之內幕消息條文（定義見上市規則） 而作出。 茲提述(i)本公司日期為 2025 年 7 月 23 日之公佈；(ii)力寶有限公司（股份代號：226） （「力寶」，本公司之居間控股公司）及 LL Capital Holdings Limited（「要約人」）所聯 合刊發日期為 2025年 7月 23日之綜合計劃文件（「計劃文件」）；及(iii)力寶及要約 ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年8月31日 狀態: 新提交 公司名稱: 力寶華潤有限公司(於香港註冊成立之有限公司) 呈交日期: 2025年9月1日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | 是 | | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00156 | 說明 | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | 法定/註冊股本 | | 上月底結存 | | | | 0 | | | | | 增加 / 減少 (-) | | | | | | | | | 本月底結存 | | | | 0 | | | | 致：香港交易及結算所有限公司 本月底法定/註冊股本總額： 第 1 頁 共 10 頁 v 1.1.1 FF301 FF301 II. 已發行股份及/或庫存股份變動 | 1. 股份分類 | 普通股 | 股份類別 | | 不適用 | | 於香港聯交所上市 ...

Core Points - The company reported a revenue of HKD 412 million for the six months ending June 30, 2025, representing a year-on-year increase of 10.15% [1] - The loss attributable to equity holders was HKD 80.345 million, a decrease of 41.48% compared to the previous year [1] - The loss per share was HKD 0.09 [1] - The reduction in loss was primarily due to a decrease in the net fair value loss of financial instruments measured at fair value through profit or loss during the period [1]

公告称，亏损减少主要由于本集团于本期间取得按公平值计入损益的财务工具的公平值亏损净额减少所 致。 智通财经APP讯，力宝华润(00156)发布截至2025年6月30日止6个月中期业绩，该集团取得收入4.12亿港 元，同比增加10.15%;公司权益持有人应占亏损8034.5万港元，同比减少41.48%;每股亏损0.09港元。 ...

（於香港註冊成立之有限公司） （股份代號：156） 中期業績 截至 2025 年 6 月 30 日止六個月 力寶華潤有限公司（「本公司」）之董事會公佈本公司及其附屬公司（統稱「本集團」）截至 2025 年 6 月 30 日 止六個月之未經審核綜合中期業績，連同 2024 年同期之比較數字如下： 香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈之內容概不負責，對其準確性或完整性亦不發表任何聲 明，並明確表示，概不對因本公佈全部或任何部份內容而產生或因倚賴該等內容而引致之任何損失承擔任何責任。 LIPPO CHINA RESOURCES LIMITED 力 寶 華 潤 有 限 公 司 簡明綜合損益表 截至 2025 年 6 月 30 日止六個月 | | | 未經審核 | | | --- | --- | --- | --- | | | | 截至 6 月 30 日止六個月 | | | | | 2025 年 | 2024 年 | | | 附註 | 千港元 | 千港元 | | 收入 | 3 | 412,108 | 374,147 | | 銷售成本 | | (155,432) | (142,651) | | | | ...

亏损减少主要由于力宝华润集团于本期间录得按公平值计入损益的财务工具的公平值亏损净额减少。 格隆汇8月25日丨力宝华润(00156.HK)公告，力宝华润董事会估计力宝华润集团于截至2025年6月30日止 六个月可能录得股东应占综合亏损不少于80,000,000港元，而上一期间则录得综合亏损137,000,000港 元。 ...

Core Viewpoint - The company anticipates a significant reduction in financial losses for the upcoming six-month period ending June 30, 2025, compared to the previous period, primarily due to decreased fair value losses on financial instruments [1] Financial Performance Summary - The company expects to incur a net fair value loss of approximately HKD 1 million for the six months ending June 30, 2025, compared to a net fair value loss of HKD 52 million for the six months ending June 30, 2024 [1] - The estimated consolidated loss attributable to shareholders for the current period is expected to be no less than HKD 80 million, a decrease from a consolidated loss of HKD 137 million in the previous period [1] - The reduction in losses is mainly attributed to a decrease in the net fair value losses on financial instruments recognized in profit or loss during the current period [1]